Annual report
2796.TEDINET S100P3F9
Period2021-06-01 → 2022-05-31
Filed2022-08-26
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 157
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥51.6bn | 2021-06-01 → 2022-05-31 | Cons. | Net sales |
| Revenue | ¥52.3bn | 2020-06-01 → 2021-05-31 | Cons. | Net sales |
| Revenue | ¥51.0bn | 2019-06-01 → 2020-05-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥51.7bn | 2018-06-01 → 2019-05-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥54.6bn | 2017-06-01 → 2018-05-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥1.5bn | 2021-06-01 → 2022-05-31 | Cons. | Operating income |
| Operating income | ¥1.2bn | 2020-06-01 → 2021-05-31 | Cons. | Operating income |
| Ordinary income | ¥1.5bn | 2021-06-01 → 2022-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.3bn | 2020-06-01 → 2021-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.0bn | 2019-06-01 → 2020-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥590m | 2018-06-01 → 2019-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.1bn | 2017-06-01 → 2018-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.3bn | 2021-06-01 → 2022-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.2bn | 2020-06-01 → 2021-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥447m | 2021-06-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥426m | 2020-06-01 → 2021-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥577m | 2019-06-01 → 2020-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥23m | 2018-06-01 → 2019-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥28m | 2017-06-01 → 2018-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥458m | 2021-06-01 → 2022-05-31 | Cons. | Profit loss |
| Net income | ¥419m | 2020-06-01 → 2021-05-31 | Cons. | Profit loss |
| Total assets | ¥23.7bn | at 2022-05-31 | Cons. | Assets |
| Total assets | ¥24.7bn | at 2021-05-31 | Cons. | Assets |
| Total assets | ¥25.2bn | at 2020-05-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥24.2bn | at 2019-05-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥24.3bn | at 2018-05-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥17.0bn | at 2022-05-31 | Cons. | Liabilities |
| Total liabilities | ¥18.4bn | at 2021-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥6.7bn | at 2022-05-31 | Cons. | Net assets |
| Net assets / equity | ¥6.3bn | at 2021-05-31 | Cons. | Net assets |
| Net assets / equity | ¥5.9bn | at 2020-05-31d | Cons. | Net assets |
| Net assets / equity | ¥5.6bn | at 2019-05-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥5.6bn | at 2018-05-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥4.0bn | at 2022-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.6bn | at 2021-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥4.0bn | at 2022-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.6bn | at 2021-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.5bn | at 2020-05-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.4bn | at 2019-05-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥3.6bn | at 2018-05-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥713m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.9bn | 2020-06-01 → 2021-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.6bn | 2019-06-01 → 2020-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥895m | 2018-06-01 → 2019-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.3bn | 2017-06-01 → 2018-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥292m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.1bn | 2020-06-01 → 2021-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥734m | 2019-06-01 → 2020-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥501m | 2018-06-01 → 2019-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥527m | 2017-06-01 → 2018-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥1.0bn | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥728m | 2020-06-01 → 2021-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥766m | 2019-06-01 → 2020-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥354m | 2018-06-01 → 2019-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥894m | 2017-06-01 → 2018-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥47.99 | 2021-06-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥45.83 | 2020-06-01 → 2021-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥61.11 | 2019-06-01 → 2020-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥2.55 | 2018-06-01 → 2019-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-3.19 | 2017-06-01 → 2018-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥36.29 | 2021-06-01 → 2022-05-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥34.64 | 2020-06-01 → 2021-05-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥46.38 | 2019-06-01 → 2020-05-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥2.24 | 2018-06-01 → 2019-05-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥684.2 | at 2022-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥646.66 | at 2021-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥613.2 | at 2020-05-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥572.74 | at 2019-05-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥585.97 | at 2018-05-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 26.9% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 24.3% | at 2021-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.6% | at 2020-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 21.9% | at 2019-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 21.8% | at 2018-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 7.2% | 2021-06-01 → 2022-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.3% | 2020-06-01 → 2021-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.5% | 2019-06-01 → 2020-05-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 0.4% | 2018-06-01 → 2019-05-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | -0.5% | 2017-06-01 → 2018-05-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,544 | at 2022-05-31 | Cons. | Number of employees |
| Employees | 1,546 | at 2021-05-31 | Cons. | Number of employees |
| Employees | 1,555 | at 2020-05-31d | Cons. | Number of employees |
| Employees | 1,455 | at 2019-05-31d | Cons. | Number of employees |
| Employees | 1,504 | at 2018-05-31d | Cons. | Number of employees |
| Revenue | ¥1.3bn | 2021-06-01 → 2022-05-31 | Standalone | Net sales |
| Revenue | ¥1.4bn | 2020-06-01 → 2021-05-31 | Standalone | Net sales |
| Revenue | ¥1.2bn | 2019-06-01 → 2020-05-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥608m | 2018-06-01 → 2019-05-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥618m | 2017-06-01 → 2018-05-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥304m | 2021-06-01 → 2022-05-31 | Standalone | Operating income |
| Operating income | ¥352m | 2020-06-01 → 2021-05-31 | Standalone | Operating income |
| Ordinary income | ¥406m | 2021-06-01 → 2022-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥428m | 2020-06-01 → 2021-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥378m | 2019-06-01 → 2020-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥307m | 2018-06-01 → 2019-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥366m | 2017-06-01 → 2018-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥208m | 2021-06-01 → 2022-05-31 | Standalone | Income before income taxes |
| Profit before tax | ¥423m | 2020-06-01 → 2021-05-31 | Standalone | Income before income taxes |
| Net income | ¥122m | 2021-06-01 → 2022-05-31 | Standalone | Profit loss |
| Net income | ¥320m | 2020-06-01 → 2021-05-31 | Standalone | Profit loss |
| Net income | ¥264m | 2019-06-01 → 2020-05-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥229m | 2018-06-01 → 2019-05-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥241m | 2017-06-01 → 2018-05-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥14.6bn | at 2022-05-31 | Standalone | Assets |
| Total assets | ¥14.9bn | at 2021-05-31 | Standalone | Assets |
| Total assets | ¥15.6bn | at 2020-05-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥15.2bn | at 2019-05-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥14.8bn | at 2018-05-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥9.8bn | at 2022-05-31 | Standalone | Liabilities |
| Total liabilities | ¥10.1bn | at 2021-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥4.8bn | at 2022-05-31 | Standalone | Net assets |
| Net assets / equity | ¥4.8bn | at 2021-05-31 | Standalone | Net assets |
| Net assets / equity | ¥4.6bn | at 2020-05-31d | Standalone | Net assets |
| Net assets / equity | ¥4.4bn | at 2019-05-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥4.2bn | at 2018-05-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.6bn | at 2022-05-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.7bn | at 2021-05-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥13.11 | 2021-06-01 → 2022-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥34.39 | 2020-06-01 → 2021-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.94 | 2019-06-01 → 2020-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥25.1 | 2018-06-01 → 2019-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥26.67 | 2017-06-01 → 2018-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥10.03 | 2021-06-01 → 2022-05-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥26.03 | 2020-06-01 → 2021-05-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥21.29 | 2019-06-01 → 2020-05-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥24.56 | 2018-06-01 → 2019-05-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥25.79 | 2017-06-01 → 2018-05-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥14 | 2021-06-01 → 2022-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥14 | 2020-06-01 → 2021-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥14 | 2019-06-01 → 2020-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥14 | 2018-06-01 → 2019-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥14 | 2017-06-01 → 2018-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥492.05 | at 2022-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥490.97 | at 2021-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥470.21 | at 2020-05-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥459.05 | at 2019-05-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥445.52 | at 2018-05-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 31.6% | at 2022-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.7% | at 2021-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.0% | at 2020-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 27.9% | at 2019-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 27.2% | at 2018-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 2.7% | 2021-06-01 → 2022-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.2% | 2020-06-01 → 2021-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.1% | 2019-06-01 → 2020-05-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.6% | 2018-06-01 → 2019-05-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.1% | 2017-06-01 → 2018-05-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 9,673,785 | at 2022-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,615,515 | at 2021-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,560,655 | at 2020-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,239,620 | at 2019-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,039,050 | at 2018-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 60 | at 2022-05-31 | Standalone | Number of employees |
| Employees | 33 | at 2021-05-31 | Standalone | Number of employees |
| Employees | 35 | at 2020-05-31d | Standalone | Number of employees |
| Employees | 72 | at 2019-05-31d | Standalone | Number of employees |
| Employees | 76 | at 2018-05-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 93
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2021-06-01 → 2022-05-31 | ¥66m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2021-06-01 → 2022-05-31 | ¥41m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2022-05-31 | 48 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-06-01 → 2022-05-31 | ¥764m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-06-01 → 2022-05-31 | ¥764m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2022-05-31 | ¥1.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-06-01 → 2022-05-31 | ¥41m |
| Reconciling Itemsreconciling | segment assets | at 2022-05-31 | ¥55m |
| Reconciling Itemsreconciling | segment profit | 2021-06-01 → 2022-05-31 | −¥294m |
| Cosmetic Drug And Convenience Storereportable segment | capex | 2021-06-01 → 2022-05-31 | ¥89m |
| Cosmetic Drug And Convenience Storereportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥44m |
| Cosmetic Drug And Convenience Storereportable segment | employees | at 2022-05-31 | 112 pure |
| Cosmetic Drug And Convenience Storereportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥7.6bn |
| Cosmetic Drug And Convenience Storereportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥7.6bn |
| Cosmetic Drug And Convenience Storereportable segment | segment assets | at 2022-05-31 | ¥1.9bn |
| Cosmetic Drug And Convenience Storereportable segment | segment profit | 2021-06-01 → 2022-05-31 | −¥146m |
| Custody Of Medical Documentsreportable segment | capex | 2021-06-01 → 2022-05-31 | ¥16m |
| Custody Of Medical Documentsreportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥41m |
| Custody Of Medical Documentsreportable segment | employees | at 2022-05-31 | 33 pure |
| Custody Of Medical Documentsreportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥699m |
| Custody Of Medical Documentsreportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥699m |
| Custody Of Medical Documentsreportable segment | segment assets | at 2022-05-31 | ¥2.0bn |
| Custody Of Medical Documentsreportable segment | segment profit | 2021-06-01 → 2022-05-31 | ¥107m |
| Dispensing Pharmacyreportable segment | capex | 2021-06-01 → 2022-05-31 | ¥356m |
| Dispensing Pharmacyreportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥415m |
| Dispensing Pharmacyreportable segment | employees | at 2022-05-31 | 1204 pure |
| Dispensing Pharmacyreportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥42.0bn |
| Dispensing Pharmacyreportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥42.0bn |
| Dispensing Pharmacyreportable segment | segment assets | at 2022-05-31 | ¥18.1bn |
| Dispensing Pharmacyreportable segment | segment profit | 2021-06-01 → 2022-05-31 | ¥1.7bn |
| Medical Mallreportable segment | capex | 2021-06-01 → 2022-05-31 | ¥23m |
| Medical Mallreportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥65m |
| Medical Mallreportable segment | employees | at 2022-05-31 | 16 pure |
| Medical Mallreportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥503m |
| Medical Mallreportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥503m |
| Medical Mallreportable segment | segment assets | at 2022-05-31 | ¥229m |
| Medical Mallreportable segment | segment profit | 2021-06-01 → 2022-05-31 | ¥67m |
| —segment total | capex | 2021-06-01 → 2022-05-31 | ¥486m |
| —segment total | depreciation | 2021-06-01 → 2022-05-31 | ¥567m |
| —segment total | revenue | 2021-06-01 → 2022-05-31 | ¥50.8bn |
| —segment total | revenue external | 2021-06-01 → 2022-05-31 | ¥50.8bn |
| —segment total | segment assets | at 2022-05-31 | ¥22.2bn |
| —segment total | segment profit | 2021-06-01 → 2022-05-31 | ¥1.8bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-06-01 → 2022-05-31 | ¥552m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-06-01 → 2022-05-31 | ¥608m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-06-01 → 2022-05-31 | ¥51.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-06-01 → 2022-05-31 | ¥51.6bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-05-31 | ¥23.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-06-01 → 2022-05-31 | ¥1.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2020-06-01 → 2021-05-31 | ¥37m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2020-06-01 → 2021-05-31 | ¥46m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2020-06-01 → 2021-05-31 | ¥716m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2020-06-01 → 2021-05-31 | ¥716m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2021-05-31 | ¥1.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2020-06-01 → 2021-05-31 | ¥40m |
| Reconciling Itemsreconciling | segment assets | at 2021-05-31 | ¥56m |
| Reconciling Itemsreconciling | segment profit | 2020-06-01 → 2021-05-31 | −¥320m |
| Cosmetic Drug And Convenience Storereportable segment | capex | 2020-06-01 → 2021-05-31 | ¥39m |
| Cosmetic Drug And Convenience Storereportable segment | depreciation | 2020-06-01 → 2021-05-31 | ¥42m |
| Cosmetic Drug And Convenience Storereportable segment | revenue | 2020-06-01 → 2021-05-31 | ¥8.0bn |
| Cosmetic Drug And Convenience Storereportable segment | revenue external | 2020-06-01 → 2021-05-31 | ¥8.0bn |
| Cosmetic Drug And Convenience Storereportable segment | segment assets | at 2021-05-31 | ¥2.0bn |
| Cosmetic Drug And Convenience Storereportable segment | segment profit | 2020-06-01 → 2021-05-31 | −¥42m |
| Custody Of Medical Documentsreportable segment | capex | 2020-06-01 → 2021-05-31 | ¥4m |
| Custody Of Medical Documentsreportable segment | depreciation | 2020-06-01 → 2021-05-31 | ¥41m |
| Custody Of Medical Documentsreportable segment | revenue | 2020-06-01 → 2021-05-31 | ¥622m |
| Custody Of Medical Documentsreportable segment | revenue external | 2020-06-01 → 2021-05-31 | ¥622m |
| Custody Of Medical Documentsreportable segment | segment assets | at 2021-05-31 | ¥2.4bn |
| Custody Of Medical Documentsreportable segment | segment profit | 2020-06-01 → 2021-05-31 | ¥64m |
| Dispensing Pharmacyreportable segment | capex | 2020-06-01 → 2021-05-31 | ¥698m |
| Dispensing Pharmacyreportable segment | depreciation | 2020-06-01 → 2021-05-31 | ¥410m |
| Dispensing Pharmacyreportable segment | revenue | 2020-06-01 → 2021-05-31 | ¥42.5bn |
| Dispensing Pharmacyreportable segment | revenue external | 2020-06-01 → 2021-05-31 | ¥42.5bn |
| Dispensing Pharmacyreportable segment | segment assets | at 2021-05-31 | ¥18.5bn |
| Dispensing Pharmacyreportable segment | segment profit | 2020-06-01 → 2021-05-31 | ¥1.4bn |
| Medical Mallreportable segment | capex | 2020-06-01 → 2021-05-31 | ¥1m |
| Medical Mallreportable segment | depreciation | 2020-06-01 → 2021-05-31 | ¥64m |
| Medical Mallreportable segment | revenue | 2020-06-01 → 2021-05-31 | ¥491m |
| Medical Mallreportable segment | revenue external | 2020-06-01 → 2021-05-31 | ¥491m |
| Medical Mallreportable segment | segment assets | at 2021-05-31 | ¥278m |
| Medical Mallreportable segment | segment profit | 2020-06-01 → 2021-05-31 | ¥60m |
| —segment total | capex | 2020-06-01 → 2021-05-31 | ¥743m |
| —segment total | depreciation | 2020-06-01 → 2021-05-31 | ¥559m |
| —segment total | revenue | 2020-06-01 → 2021-05-31 | ¥51.6bn |
| —segment total | revenue external | 2020-06-01 → 2021-05-31 | ¥51.6bn |
| —segment total | segment assets | at 2021-05-31 | ¥23.1bn |
| —segment total | segment profit | 2020-06-01 → 2021-05-31 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2020-06-01 → 2021-05-31 | ¥780m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2020-06-01 → 2021-05-31 | ¥606m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-06-01 → 2021-05-31 | ¥52.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-06-01 → 2021-05-31 | ¥52.3bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-05-31 | ¥24.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-06-01 → 2021-05-31 | ¥1.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,583
| Item | Context | Value | Unit |
|---|---|---|---|
| Overview of affiliated entities (text) | FilingDateInstant | Text · Plus | |
| Information about employees (text) | FilingDateInstant | Text · Plus | |
| Business policy business environment issues to address etc (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Research and development activities (text) | FilingDateInstant | Text · Plus | |
| Overview of capital expenditures etc (text) | FilingDateInstant | Text · Plus | |
| Major facilities (text) | FilingDateInstant | Text · Plus | |
| Planned additions retirements etc of facilities (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所（プライム市場） | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)単元株式数100株 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Description of rights plan (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Shareholding by shareholder category (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Name major shareholders | CurrentYearInstant_No1MajorShareholdersMember | Original text (Japanese)㈱ビックフィールド | |
| Address major shareholders | CurrentYearInstant_No1MajorShareholdersMember | Original text (Japanese)東京都杉並区南荻窪２-18-14 | |
| Name major shareholders | CurrentYearInstant_No2MajorShareholdersMember | Original text (Japanese)日本マスタートラスト信託銀行㈱ | |
| Address major shareholders | CurrentYearInstant_No2MajorShareholdersMember | Original text (Japanese)東京都港区浜松町２-11-３ | |
| Name major shareholders | CurrentYearInstant_No3MajorShareholdersMember | Original text (Japanese)中北薬品㈱ | |
| Address major shareholders | CurrentYearInstant_No3MajorShareholdersMember | Original text (Japanese)愛知県名古屋市中区丸の内３-11-９ | |
| Name major shareholders | CurrentYearInstant_No4MajorShareholdersMember | Original text (Japanese)㈱バイタルネット | |
| Address major shareholders | CurrentYearInstant_No4MajorShareholdersMember | Original text (Japanese)宮城県仙台市青葉区大手町１-１ | |
| Name major shareholders | CurrentYearInstant_No5MajorShareholdersMember | Original text (Japanese)㈱ほくやく | |
| Address major shareholders | CurrentYearInstant_No5MajorShareholdersMember | Original text (Japanese)北海道札幌市中央区北六条西16-１-５ | |
| Name major shareholders | CurrentYearInstant_No6MajorShareholdersMember | Original text (Japanese)ファーマライズ従業員持株会 | |
| Address major shareholders | CurrentYearInstant_No6MajorShareholdersMember | Original text (Japanese)東京都中野区中央１-38-１ | |
| Name major shareholders | CurrentYearInstant_No7MajorShareholdersMember | Original text (Japanese)大野 小夜子 | |
| Address major shareholders | CurrentYearInstant_No7MajorShareholdersMember | Original text (Japanese)東京都杉並区 | |
| Name major shareholders | CurrentYearInstant_No8MajorShareholdersMember | Original text (Japanese)ヒグチ産業㈱ | |
| Address major shareholders | CurrentYearInstant_No8MajorShareholdersMember | Original text (Japanese)大阪府東大阪市鴻池徳庵町１-６ | |
| Name major shareholders | CurrentYearInstant_No9MajorShareholdersMember | Original text (Japanese)大野 利美知 | |
| Address major shareholders | CurrentYearInstant_No9MajorShareholdersMember | Original text (Japanese)東京都杉並区 | |
| Name major shareholders | CurrentYearInstant_No10MajorShareholdersMember | Original text (Japanese)ＡＧ２号投資事業有限責任組合 | |
| Address major shareholders | CurrentYearInstant_No10MajorShareholdersMember | Original text (Japanese)東京都港区赤坂２-23-１ | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentYearInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | Original text (Japanese)自己保有株式 | |
| Description issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | Original text (Japanese)権利内容に何ら限定のない当社における標準となる株式単元株式数100株 | |
| Description issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | Original text (Japanese)同上 | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |